Key Events This Week
29 Jun: Technical momentum shifts signal mildly bullish outlook
2 Jul: Mojo Grade upgraded to Buy following strong technical and financial results
2 Jul: Technical momentum further upgraded to bullish stance
3 Jul: Week closes at Rs.6,361.45 with a slight dip of -1.54%

Procter & Gamble Health Ltd Upgraded to Buy on Strong Technical and Financial Performance
2026-07-02 08:19:14Procter & Gamble Health Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, robust financial results, and a favourable valuation outlook. The company’s strong quarterly performance, coupled with bullish technical trends and solid management efficiency, has prompted analysts to revise their stance on this small-cap pharmaceutical player.
Read full news article
Procter & Gamble Health Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-07-02 08:02:49Procter & Gamble Health Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a combination of positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside a robust price performance that outpaces the broader market benchmarks.
Read full news article
Procter & Gamble Health Ltd is Rated Hold
2026-07-01 10:10:03Procter & Gamble Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
Procter & Gamble Health Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-06-29 08:00:45Procter & Gamble Health Ltd (P&G Health) has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip of 0.13% on the day, the stock’s technical indicators present a nuanced picture, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This analysis delves into these technical parameters, contextualising the stock’s performance against broader market benchmarks and its own historical returns.
Read full news article
Golden Cross Forms in Procter & Gamble Health Ltd — On a Day the Stock Fell 0.13%. What the Mixed Signals Mean
2026-06-25 18:00:31The 50-day moving average has crossed above the 200-day moving average for Procter & Gamble Health Ltd, signalling a golden cross on 25 Jun 2026. Yet, the stock slipped 0.13% on the day the cross formed, while monthly technical indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context.
Read full news article
Procter & Gamble Health Ltd is Rated Hold
2026-06-20 10:10:42Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 June 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read full news article







